No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text component.
Seventy-nine patients (83%) had a Groshong CVC (Bard Access System, Salt Lake City, UT), and 16 (17%) had a Port-a-Cath device (Bard Access System). All patients received oral warfarin at a dose of 1 ...
One of the main problems in interpreting the literature concerning infectious complications of CVCs is the inconsistent use of terms and definitions. Furthermore, it is often unclear exactly how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results